We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Janssen #AdVac technology is a technology based on the #adenovirus vector that can be used together with PER.C6 technology to develop recombinant #vaccines against life-threatening infectious diseases.